Trial · NCT06713785
Personalised Electronic Record Supported Optimisation of Amlodipine for Patients With Hypertension
NCT06713785, Phase 4, Withdrawn, Queen Mary University of London
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Personalised Electronic Record Supported Optimisation of Amlodipine for Patients With Hypertension. Trials, record NCT06713785. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT06713785
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Personalised Electronic Record Supported Optimisation of Amlodipine for Patients With Hypertension
- NCT number
- NCT06713785
- Status
- Withdrawn
- Phases
- Phase 4
- Enrollment
- 0 participants, actual
- Lead sponsor
- Queen Mary University of London
- Conditions
- Hypertension
- Interventions
- Amlodipine
- First posted
- 2024-12-03
- Last updated
- 2024-12-03
Source ClinicalTrials.gov
Registered outcomes9
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | The difference in daytime ambulatory systolic blood pressure between baseline ABPM and post-titration ABPM on a personalized dose of amlodipine. | End of study 1 year | pressure between baseline ABPM and post-titration ABPM on a personalized dose of amlodipine. |
| Secondary | Other clinically significant blood pressure measures which related to difference in measured blood pressure between baseline and EOS, especially AOBP clinic BP readings and home BP readings | End of study 1 year | Other clinically significant blood pressure measures which related to difference in measured blood pressure between baseline and EOS, especially AOBP clinic BP readings and home BP readings |
| Secondary | Feasibility of collecting data using a digital diary | End of study 1 year | Feasibility of collecting data using a digital diary |
| Secondary | Collect patient reported outcome data including satisfaction with medication regime using digital diary | Collect patient reported outcome data including satisfaction with medication regime using digital diary | Collect patient reported outcome data including satisfaction with medication regime using digital diary |
| Secondary | Patient feedback on the use of digital diary | End of study 1 year | Patient feedback on the use of digital diary |
| Secondary | Insight into number of patients achieving target BP of <135 and 85 at EOS | End of study 1 year | Insight into number of patients achieving target BP of \<135 and 85 at EOS |
| Secondary | Insight into number of patients achieving reduction in systolic BP of ≥5mmHg at EOS | End of Study | Insight into number of patients achieving reduction in systolic BP of ≥5mmHg at EOS |
| Secondary | Insight into number of patients achieving reduction in systolic BP of ≥10mmHg EOS | EOS 1 year | Insight into number of patients achieving reduction in systolic BP of ≥10mmHg EOS |
| Secondary | Insight into number of patients achieving reduction in diastolic BP of ≥5mmHg at EOS | End of study 1 year | Insight into number of patients achieving reduction in diastolic BP of ≥5mmHg at EOS |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT06713785
GET https://conductscience.org/api/trials/v1/NCT06713785/registered